- Filed
- May 20, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 225.15M sh |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 224.35M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2025 | −€41.37M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −€96.55M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | €438.33M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | €481.75M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | €300.15M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2023 | €402.45M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | €646.69M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | €696.61M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | €446.91M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | €516.94M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | €61.29M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | €72.35M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | €95.58M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | €106.22M |
| Current Assets | Q1 2025 · Mar 31, 2025 | €469.1M |
| Current Assets | Q1 2025 · Dec 31, 2024 | €526.41M |
| Total Assets | Q1 2025 · Mar 31, 2025 | €742.27M |
| Total Assets | Q1 2025 · Dec 31, 2024 | €802.83M |
| Eps Diluted | Q1 2025 · Mar 31, 2025 | −€0.23 |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −€0.31 |
| Eps Basic | Q1 2025 · Mar 31, 2025 | −€0.23 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −€0.31 |
| Rd Expense | Q1 2025 · Mar 31, 2025 | €37.59M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | €27.83M |
| Net Income | Q1 2025 · Mar 31, 2025 | −€52.08M |
| Net Income | Q1 2025 · Mar 31, 2024 | −€70.55M |
| Operating Income | Q1 2025 · Mar 31, 2025 | −€54.73M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −€73.32M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2025 | €875K |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | €41.69M |